Prevention of biofilm formation

Patent metadata

Field	Value
Publication number	US-11560484-B2
Application number	US-201916678076-A
Country	US
Kind code	B2
Filing date	Nov 8, 2019
Priority date	Mar 30, 2017
Publication date	Jan 24, 2023
Grant date	Jan 24, 2023

Abstract

Antibacterial coatings and methods of making the antibacterial coatings are described herein. A first branched polyethylenimine (BPEI) layer is formed and a first glyoxal layer is formed on a surface of the BPEI layer. The first BPEI layer and the first glyoxal layer are cured to form a crosslinked BPEI coating. The first BPEI layer can be modified with superhydrophobic moieties, superhydrophilic moieties, or negatively charged moieties to increase the antifouling characteristics of the coating. The first BPEI layer can be modified with contact-killing bactericidal moieties to increase the bactericidal characteristics of the coating.

First claim

What is claimed is:

1. An apparatus, the apparatus comprising:
an implantable medical device; and
a glyoxal-crosslinked branched polyethylenimine (BPEI) coating formed on a surface of the implantable medical device;
wherein amines of the BPEI coating are covalently bonded to superhydrophobic moieties or negatively-charged moieties.

2. The apparatus of claim 1 , wherein the implantable medical device further comprises a power source.

3. The apparatus of claim 2 , wherein the power source is embedded within the implantable medical device.

4. The apparatus of claim 3 , wherein the power source comprises a battery.

5. The apparatus of claim 3 , wherein the power source comprises a microcapacitor coupled to the negatively charged coating through an electrode.

6. The apparatus of claim 1 , wherein the implantable medical device is selected from the group consisting of a prosthetic heart valve, a left ventricular assist device, vascular stents, vascular grafts, a prosthetic joint, a bone implant, an implanted tooth, an implanted pacemaker, a pacemaker generator or wires, an intravascular line, a ventriculoperitoneal shunt, a urinary catheter, an eye implant, an intracranial implant, or a subcutaneous implant.

7. The apparatus of claim 1 further comprising additional layers of gloxal-crosslinked branched BPEI.

8. An apparatus, the apparatus comprising:
a substrate; and
a glyoxal-crosslinked branched polyethylenimine (BPEI) coating formed on a surface of the substrate;
wherein amines of the glyoxal-crosslinked BPEI coating are covalently bonded to hydrophobic moieties or negatively-charged moieties.

9. An apparatus comprising:
an implantable medical device; and
a negatively charged coating formed on a surface of the implantable medical device wherein a polymer of the negatively charged coating comprises one of hydroxyapatite and poly(3,4-ethylenedioxythiophene) (PEDOT); and
wherein the polymer is functionalized with a bio-compatible moiety comprising one of a carboxylic negative group and a polystyrene sulfonate group.

10. The apparatus of claim 9 , wherein the implantable medical device is selected from the group consisting of a prosthetic heart valve, a left ventricular assist device, vascular stents, vascular grafts, a prosthetic joint, a bone implant, an implanted tooth, an implanted pacemaker, a pacemaker generator or wires, an intravascular line, a ventriculoperitoneal shunt, a urinary catheter, an eye implant, an intracranial implant, or a subcutaneous implant.

11. The apparatus of claim 9 , further comprising a power source embedded within the implantable medical device.

12. The apparatus of claim 11 , wherein the negatively charged coating is maintained by the power source.

13. The apparatus of claim 12 , wherein the power source comprises a battery.

14. The apparatus of claim 12 , wherein the power source comprises a microcapacitor coupled to the negatively charged coating through an electrode.

15. The apparatus of claim 12 , wherein the power source is triggered to maintain the negatively charged coating by a change in local pH.

16. The apparatus of claim 12 , wherein the power source is triggered to maintain the negatively charged coating by a rise in body temperature.

17. The apparatus of claim 12 , wherein the power source is triggered to maintain the negatively charged coating for a period of time following implantation of the implantable medical device.

18. The apparatus of claim 12 , wherein the power source is triggered to maintain the negatively charged coating for a period of time determined by a control signal received from a remote location.

19. The apparatus of claim 18 , wherein the control signal is received from the remote location through a wireless transmitter.

20. The apparatus of claim 19 , wherein the wireless transmitter is embedded within the implantable medical device.

Assignees

• IBM
• Inst Of Bioengineering And Nanotechnology

Inventors

• Cahan Amos
• Deligianni Hariklia
• Ding Xin
• Fevre Mareva B
• Hedrick James L
• Hsueh Pei-Yun S
• Liang zhen chang
• Park Nathaniel H
• Van Kessel Theodore G
• Wojtecki Rudy J
• Yang Yi Yan

Classifications

• A61F2/07

  Stent-grafts · CPC title

• A61F2002/3006

  Properties of materials and coating materials · CPC title

• A61F2/30

  Joints · CPC title

• A61M2025/0056

  provided with an antibacterial agent, e.g. by coating, residing in the polymer matrix or releasing an agent out of a reservoir · CPC title

• A61F2/14

  Eye parts, e.g. lenses or corneal implants; Artificial eyes · CPC title